20(R)-Ginsenoside Rh2>97.0%(HPLC)5mg

tBuXPhos Pd G3, >98.0%, 250mg

(3,6-Dichloro-2-fluorophenyl)boronic acid, 98%, 1g

DL-Tropic Acid>98.0%(GC)(T)25g

Thiophen-2(5h)-one, 97%, 10g

(R)-tert-Butyl 3-(trifluoromethyl)piperazine-1-carboxylate, 97%, 100mg

(R)-4-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 100mg

Methyl 5-(chlorosulfonyl)-1-methyl-1H-pyrrole-2-carboxylate, 95.0%, 250mg

METHYL 2-OXO-2-(1H-PYRROL-2-YL)ACETATE, 95.0%, 1g

2-Bromo-4-fluorobenzonitrile>98.0%(GC)25g

Sodium formate-d, 10g

4,7-Bis(5-bromo-2-thienyl)-2,1,3-benzothiadiazole>95.0%(HPLC)(N)100mg

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)